Leukemia, Lymphocytic, Chronic, B-Cell
Showing 9976 - 10000 of >10,000
Stage II Renal Cell Cancer, Stage III Renal Cell Cancer Trial (tivozanib, therapeutic conventional surgery)
Withdrawn
- Stage II Renal Cell Cancer
- Stage III Renal Cell Cancer
- tivozanib
- therapeutic conventional surgery
- (no location specified)
Aug 11, 2022
Relapsed T-Cell Acute Lymphoblastic Leukemia, Relapsed T-Cell Lymphoblastic Lymphoma Trial in Worldwide (Nelarabine, Etoposide,
Terminated
- Relapsed T-Cell Acute Lymphoblastic Leukemia
- Relapsed T-Cell Lymphoblastic Lymphoma
- Nelarabine
- +4 more
-
Los Angeles, California
- +36 more
Sep 8, 2020
Delirium in Children Undergoing Stem Cell Transplantation
Recruiting
- Stem Cell Transplant Complications
- Delirium
- Daily screening for delirium
-
San Francisco, California
- +5 more
Sep 13, 2022
Epstein-Barr Virus Infections, Lymphoma, Lymphoproliferative Disorder Trial run by the NCI (Nivolumab)
Recruiting
- Epstein-Barr Virus Infections
- +3 more
- Nivolumab
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 24, 2023
Kidney Cancer Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (cell infusion)
Recruiting
- Kidney Cancer
- cell infusion
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 2, 2022
Gingival Recession Trial in Rohtak (Periodontal plastic surgery procedure and orthodontic treatment, Periodontal plastic surgery
Completed
- Gingival Recession
- Periodontal plastic surgery procedure and orthodontic treatment
- Periodontal plastic surgery procedure
-
Rohtak, Haryana, IndiaPost Graduate Institute of Dental Sciences
Aug 19, 2022
NSCLC Trial in Hangzhou, Nanjing (IBI308, Docetaxel)
Active, not recruiting
- Non-small Cell Lung Cancer
-
Hangzhou, Zhejiang, China
- +1 more
Jun 1, 2021
Plaque Psoriasis Trial in Russian Federation (Adalimumab, Humira)
Not yet recruiting
- Plaque Psoriasis
-
Barnaul, Russian Federation
- +8 more
Aug 21, 2023
Toxicity, Drug Trial in Hefei (neoadjuvant chemoradiotherapy combined with Camrelizumab and Nimotuzumab followed by surgery)
Recruiting
- Toxicity, Drug
- neoadjuvant chemoradiotherapy combined with Camrelizumab and Nimotuzumab followed by surgery
-
Hefei, Anhui, ChinaAnhui Provicial Hospital
May 1, 2022
HER2-positive Breast Cancer Trial in Tampa (biological, drug, procedure)
Recruiting
- HER2-positive Breast Cancer
- HER-2 pulsed DC1
- +4 more
-
Tampa, FloridaMoffitt Cancer Center
Oct 6, 2022
Pediatric Patients With Cystic Fibrosis in Sohag.
Recruiting
- Cystic Fibrosis
- sweat chloride test
- genetic testing
-
Sohag, EgyptSohag University Hospital
Dec 29, 2022
Advanced Renal Cell Carcinoma Trial in Beijing (ST-1898 tablets)
Recruiting
- Advanced Renal Cell Carcinoma
- ST-1898 tablets
-
Beijing, Beijing, ChinaPeking University Cancer Hospital & Institute
Nov 6, 2023
Chronic Low-back Pain Trial in Famagusta (Instrument Assisted Soft Tissue Mobilization Group While Lying Prone, Instrument
Not yet recruiting
- Chronic Low-back Pain
- Instrument Assisted Soft Tissue Mobilization Group While Lying Prone
- Instrument Assisted Soft Tissue Mobilization Group Combined with Functional Movement
-
Famagusta, CyprusSüleyman Güzelşemme
Nov 14, 2022
Low Back Pain Trial in Natal (Exercises and dry cupping)
Not yet recruiting
- Low Back Pain
- Exercises and dry cupping
-
Natal, RN, BrazilMarcelo Cardoso de Souza
Jul 13, 2022
Cutaneous T-cell Lymphoma Retreated With Brentuximab Vedotin
Not yet recruiting
- T-Cell Lymphoma
- No intervention
-
Bordeaux, France
- +10 more
May 24, 2023
Pediatric Sarcoma, Refractory, Pediatric Sarcoma, Relapsed Trial in Tampa, Columbus (GEM/DOX + TGFBi expanded NK cells)
Recruiting
- Pediatric Sarcoma, Refractory
- Pediatric Sarcoma, Relapsed
- GEM/DOX + TGFBi expanded NK cells
-
Tampa, Florida
- +1 more
Jan 3, 2023
Refractory Diffuse Large B-cell Lymphoma Trial (Rituximab Paclitaxel Ruxolitinib)
Not yet recruiting
- Refractory Diffuse Large B-cell Lymphoma
- Rituximab Paclitaxel Ruxolitinib
- (no location specified)
Apr 19, 2021
Celiac Disease in Children, Type 1 Diabetes, Thyroid Trial in Malmö (Probiotic, Placebo)
Recruiting
- Celiac Disease in Children
- +2 more
- Probiotic
- Placebo
-
Malmö, SwedenClinical Research Center (CRC), Bldng 60:11
Apr 5, 2022
Mental Health Trial in United States (Implementation Facilitation, Centralized Technical Assistance)
Recruiting
- Mental Health
- Implementation Facilitation
- Centralized Technical Assistance
-
Palo Alto, California
- +8 more
Aug 11, 2023
Bone Marrow Biopsy Procedure Trial in Milwaukee (Ultrasound-assisted bone marrow biopsy, Landmark palpation bone marrow biopsy)
Recruiting
- Bone Marrow Biopsy Procedure
- Ultrasound-assisted bone marrow biopsy
- Landmark palpation bone marrow biopsy
-
Milwaukee, WisconsinFroedtert Hospital
May 19, 2022
Chronic Pain, Arthritis Hand, Opioid Use Trial in San Diego (Standard of care, Nottingham AR smartphone app with active
Recruiting
- Chronic Pain
- +2 more
- Standard of care
- Nottingham AR smartphone app with active intervention
-
San Diego, CaliforniaVA San Diego Healthcare System
Dec 5, 2022
Moderate-to-Severe Plaque Psoriasis Trial in Shenyang (Jaktinib, Placebo)
Recruiting
- Moderate-to-Severe Plaque Psoriasis
- Jaktinib
- Placebo
-
Shenyang, Liaoning, ChinaThe First Affiliated Hospital of China Medical University
Nov 28, 2022
Factors in Patients With Primary Central Nervous System Lymphoma
Recruiting
- PCNSL
- Survival Analysis
- prognostic marker
-
Zhengzhou, Henan, ChinaZhengzhou university
Dec 12, 2021
Heart Failure, Hypertension, Left Ventricle Remodeling Trial (Empagliflozin 10 MG, Placebo)
Not yet recruiting
- Heart Failure
- +3 more
- Empagliflozin 10 MG
- Placebo
- (no location specified)
Sep 20, 2023